Mohinder S. Kang

897 total citations
18 papers, 782 citations indexed

About

Mohinder S. Kang is a scholar working on Molecular Biology, Organic Chemistry and Biotechnology. According to data from OpenAlex, Mohinder S. Kang has authored 18 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Biotechnology. Recurrent topics in Mohinder S. Kang's work include Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Enzyme Production and Characterization (4 papers). Mohinder S. Kang is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Enzyme Production and Characterization (4 papers). Mohinder S. Kang collaborates with scholars based in United States, United Kingdom and France. Mohinder S. Kang's co-authors include Kenneth M. Yamada, Masanobu Obara, Prasad S. Sunkara, Paul S. Liu, Enrico Cabib, Alan D. Elbein, A.S. Tyms, Terry L. Bowlin, Debra L. Taylor and Roland S. Rogers and has published in prestigious journals such as Cell, PLANT PHYSIOLOGY and Analytical Biochemistry.

In The Last Decade

Mohinder S. Kang

18 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohinder S. Kang United States 12 336 289 234 145 99 18 782
Mary Ellen K. Salyan United States 20 718 2.1× 125 0.4× 234 1.0× 140 1.0× 36 0.4× 31 1.0k
A.F. Moon United States 21 944 2.8× 146 0.5× 143 0.6× 239 1.6× 92 0.9× 27 1.3k
Mayumi Ishihara United States 18 728 2.2× 118 0.4× 219 0.9× 128 0.9× 44 0.4× 35 1.1k
Paul A. Aeed United States 11 302 0.9× 178 0.6× 58 0.2× 51 0.4× 51 0.5× 17 532
Arun K. Sarkar United States 12 503 1.5× 71 0.2× 346 1.5× 158 1.1× 15 0.2× 26 787
Selma Silagi United States 18 541 1.6× 93 0.3× 45 0.2× 150 1.0× 126 1.3× 34 1.0k
Chun‐Ting Yuen United Kingdom 18 789 2.3× 84 0.3× 241 1.0× 164 1.1× 22 0.2× 31 1.1k
Barry Potvin United States 15 778 2.3× 99 0.3× 186 0.8× 78 0.5× 20 0.2× 18 898
J E Oates United Kingdom 11 721 2.1× 88 0.3× 351 1.5× 141 1.0× 15 0.2× 12 1.0k
J. L. ABERNETHY United States 9 387 1.2× 60 0.2× 183 0.8× 196 1.4× 11 0.1× 10 570

Countries citing papers authored by Mohinder S. Kang

Since Specialization
Citations

This map shows the geographic impact of Mohinder S. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohinder S. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohinder S. Kang more than expected).

Fields of papers citing papers by Mohinder S. Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohinder S. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohinder S. Kang. The network helps show where Mohinder S. Kang may publish in the future.

Co-authorship network of co-authors of Mohinder S. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Mohinder S. Kang. A scholar is included among the top collaborators of Mohinder S. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohinder S. Kang. Mohinder S. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kang, Mohinder S.. (1996). Uptake and metabolism of BuCast: a glycoprotein processing inhibitor and a potential anti-HIV drug. Glycobiology. 6(2). 209–216. 16 indexed citations
2.
Bridges, C G, et al.. (1995). The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection. Glycobiology. 5(2). 249–253. 42 indexed citations
4.
Kang, Mohinder S., et al.. (1995). Castanospermine analogues: their inhibition of glycoprotein processing α-glucosidases from porcine kidney and B16F10 cells. Glycobiology. 5(1). 147–152. 16 indexed citations
5.
Kang, Mohinder S., et al.. (1993). Accumulation of pentamannose oligosaccharides in human mononuclear leukocytes by action of swainsonine, an inhibitor of glycoprotein processing. Carbohydrate Research. 248. 327–337. 7 indexed citations
6.
Taylor, Debra L., Prasad S. Sunkara, Paul S. Liu, et al.. (1991). 6–0-Butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs. AIDS. 5(6). 693–698. 72 indexed citations
7.
Liu, Paul S., Roland S. Rogers, Mohinder S. Kang, & Prasad S. Sunkara. (1991). Synthesis of polyhydroxylated indolizidine and quinolizidine compounds--potent inhibitors of α-glucosidase I. Tetrahedron Letters. 32(42). 5853–5856. 36 indexed citations
8.
Liu, Paul S., Mohinder S. Kang, & Prasad S. Sunkara. (1991). A potent inhibitor of β--acetylglucosaminidases: 6-acetamido-6-deoxycastanospermine. Tetrahedron Letters. 32(6). 719–720. 32 indexed citations
9.
Sunkara, Prasad S., Mohinder S. Kang, Terry L. Bowlin, et al.. (1990). Inhibition of Glycoprotein Processing and HIV Replication by Castanospermine Analogues. Annals of the New York Academy of Sciences. 616(1). 90–96. 24 indexed citations
10.
Kang, Mohinder S., et al.. (1989). A simple and rapid microplate assay for glycoprotein-processing glycosidases. Analytical Biochemistry. 181(1). 109–112. 9 indexed citations
11.
Obara, Masanobu, Mohinder S. Kang, & Kenneth M. Yamada. (1988). Site-directed mutagenesis of the cell-binding domain of human fibronectin: Separable, synergistic sites mediate adhesive function. Cell. 53(4). 649–657. 339 indexed citations
12.
Obara, Masanobu, Mohinder S. Kang, Sylvie Dufour, et al.. (1987). Expression of the cell‐binding domain of human fibronectin in E. coli. FEBS Letters. 213(2). 261–264. 30 indexed citations
13.
Cabib, Enrico & Mohinder S. Kang. (1987). [55] Fungal 1,3-β-glucan synthase. Methods in enzymology on CD-ROM/Methods in enzymology. 138. 637–642. 56 indexed citations
14.
Cabib, Enrico, Mohinder S. Kang, & Janice Au-Young. (1987). [56] Chitin synthase from Saccharomyces cerevisiae. Methods in enzymology on CD-ROM/Methods in enzymology. 138. 643–649. 11 indexed citations
15.
Kang, Mohinder S., Paul J. Szaniszlo, Vicente Notario, & Enrico Cabib. (1986). The effect of papulacandin B on (1→3)-β-d-glucan synthetases. A possible relationship between inhibition and enzyme conformation. Carbohydrate Research. 149(1). 13–21. 11 indexed citations
16.
Prakash, Chandra, et al.. (1984). Solubilization of mannosyltransferase activities for the biosynthesis of mammary glycoproteins. European Journal of Biochemistry. 139(1). 87–93. 7 indexed citations
17.
Kang, Mohinder S. & Alan D. Elbein. (1983). Mechanism of Inhibition of Jack Bean α-Mannosidase by Swainsonine. PLANT PHYSIOLOGY. 71(3). 551–554. 56 indexed citations
18.
Kang, Mohinder S. & A D Elbein. (1979). Incorporation of glucose into lipid-linked saccharides in aorta and its inhibition by amphomycin. Archives of Biochemistry and Biophysics. 198(1). 304–313. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026